These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21347316)

  • 1. Mitigation strategies for pandemic influenza A: balancing conflicting policy objectives.
    Hollingsworth TD; Klinkenberg D; Heesterbeek H; Anderson RM
    PLoS Comput Biol; 2011 Feb; 7(2):e1001076. PubMed ID: 21347316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness.
    Halder N; Kelso JK; Milne GJ
    BMC Infect Dis; 2014 May; 14():266. PubMed ID: 24884470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis.
    Kelso JK; Halder N; Milne GJ
    BMC Infect Dis; 2013 Feb; 13():81. PubMed ID: 23398722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic influenza.
    Dimitrov NB; Goll S; Hupert N; Pourbohloul B; Meyers LA
    PLoS One; 2011 Jan; 6(1):e16094. PubMed ID: 21283514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response.
    McVernon J; McCaw JM; Nolan TM
    Aust N Z J Public Health; 2010 Apr; 34(2):113-9. PubMed ID: 23331352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can informal social distancing interventions minimize demand for antiviral treatment during a severe pandemic?
    Greer AL
    BMC Public Health; 2013 Jul; 13():669. PubMed ID: 23866760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for mitigating an influenza pandemic.
    Ferguson NM; Cummings DA; Fraser C; Cajka JC; Cooley PC; Burke DS
    Nature; 2006 Jul; 442(7101):448-52. PubMed ID: 16642006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy.
    Ajelli M; Merler S; Pugliese A; Rizzo C
    Epidemiol Infect; 2011 Jan; 139(1):68-79. PubMed ID: 20546633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the effectiveness of interventions used during the 2009 A/H1N1 influenza pandemic.
    Halder N; Kelso JK; Milne GJ
    BMC Public Health; 2010 Mar; 10():168. PubMed ID: 20346187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal vaccine allocation for the early mitigation of pandemic influenza.
    Matrajt L; Halloran ME; Longini IM
    PLoS Comput Biol; 2013; 9(3):e1002964. PubMed ID: 23555207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral treatment for pandemic influenza: assessing potential repercussions using a seasonally forced SIR model.
    Towers S; Vogt Geisse K; Zheng Y; Feng Z
    J Theor Biol; 2011 Nov; 289():259-68. PubMed ID: 21867715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands.
    Nuño M; Chowell G; Gumel AB
    J R Soc Interface; 2007 Jun; 4(14):505-21. PubMed ID: 17251132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of school closures on pandemic influenza: Assessing potential repercussions using a seasonal SIR model.
    Towers S; Geisse KV; Tsai CC; Han Q; Feng Z
    Math Biosci Eng; 2012 Apr; 9(2):413-30. PubMed ID: 22901071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts.
    Postma MJ; Milne G; Nelson EA; Pyenson B; Basili M; Coker R; Oxford J; Garrison LP;
    Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1431-9. PubMed ID: 21133667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories.
    Kelso JK; Halder N; Postma MJ; Milne GJ
    BMC Public Health; 2013 Mar; 13():211. PubMed ID: 23496898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.
    Prosper O; Saucedo O; Thompson D; Torres-Garcia G; Wang X; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):141-70. PubMed ID: 21361405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study.
    Khazeni N; Hutton DW; Collins CI; Garber AM; Owens DK
    Ann Intern Med; 2014 May; 160(10):684-94. PubMed ID: 24842415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can antiviral drugs contain pandemic influenza transmission?
    Becker NG; Wang D
    PLoS One; 2011 Mar; 6(3):e17764. PubMed ID: 21464934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are we prepared for the next influenza pandemic? Lessons from modelling different preparedness policies against four pandemic scenarios.
    Panovska-Griffiths J; Grieco L; van Leeuwen E; Baguelin M; Pebody R; Utley M
    J Theor Biol; 2019 Nov; 481():223-232. PubMed ID: 31059716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza pandemic intervention planning using InfluSim: pharmaceutical and non- pharmaceutical interventions.
    Duerr HP; Brockmann SO; Piechotowski I; Schwehm M; Eichner M
    BMC Infect Dis; 2007 Jul; 7():76. PubMed ID: 17629919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.